spleen cells of arthritic rats have a marked impairment in their ability to respond in vitro to mitogenic stimuli. Furthermore we have examined the temporal relationship between altered spleen cell function and the development of arthritis, the contribution of prostaglandins (PGE2), and the possibility that altered regulation of lymphocyte responses by interleukins 1 and 2 (IL-1, IL-2) may contribute to this functional deficit. The results suggest that the deficient responsiveness of spleen cells from arthritic rats is not prostaglandin-mediated but results from a diminished ability of lymphoid cells from arthritic animals to produce and respond to IL-2.
Materials and methods
Animals. Male Lewis and Buffalo rats (150-170 g, Charles River, Wilmington, MA) were housed under standard laboratory conditions and fed food and water ad libitum.
Induction of arthritis. Groups of 8-10 rats were injected in the right hind footpad with 0 5 mg Mycobacterium butyricum suspended in 0-1 ml of light mineral oil (Difco Laboratories, Detroit, MI). The development of arthritis was quantitated by measuring paw volumes (ml) at various intervals with a mercury plethysmograph.13
Cell culture. Spleens from two to four rats were removed aseptically and pooled, and single cell suspensions were prepared by passage through wire mesh screens. The cells were incubated for 10 min on ice with trometamol (tris)-buffered ammonium chloride (17 mM tris-146 mM NH4Cl, pH to lyse erythrocytes and were washed three times in RPMI 1640 medium (containing 20 mM glutamine, 20 mM HEPES, 10% bovine calf serum, 50 [g/ml streptomycin, 50 U/ml penicillin, and 5x 10 Lewis rat thymocytes/0-2 ml medium were cultured for three days with 20 tg/ml PHA plus varying dilutions of test supernatant.14 IL-1 activity was calculated by subtracting the disintegrations per minute (dpm) of thymocytes cultured with PHA alone from the dpm in thymocytes cultured with PHA plus test supernatant (A dpm). Supernates from LPS-activated adherent cell cultures were routinely negative when tested for IL-2 by the CTLL-2 assay (see below).
The ability of spleen cells to produce IL-2 was assessed by culturing lx 106 spleen cells for 24 h in 1*0 ml medium containing 0-1-1 itg con A or 50-100 ig/ml PHA. Supernatant fluids were then tested for IL-2 activity by the IL-2-dependent mouse cytotoxic T cell line, CTLL-2, as previously described. Table 1) . Kinetics of spleen cell hyporesponsiveness in relation to the development of arthritis. Fig. 2 shows that the time course of development of arthritis (as measured by paw oedema) and the development of splenic hyporesponsiveness to mitogenic stimulation were similar. Within 24 h of injection of M. butyricum a non-specific inflammatory response occurred in the injected paw. By day 8-10 both the injected and uninjected paws began to show a significant arthritic response, which increased rapidly until day 16-22, after which no further increases in paw oedema were noted. Spleen cell hyporesponsiveness to PHA in vitro developed in parallel with the arthritic response but was first evident by day 4, (Table 2) .
Interleukin synthesis by spleen cells from normal and arthritic rats. Since interleukins 1 and 2 are important soluble mediators necessary for optimal in-vitro T cell proliferation,1617 we examined the possibility that 'arthritic' spleen cells were deficient in their ability to produce or utilise these lymphokines. Fig. 3 shows that LPS-stimulated adherent spleen cells from arthritic rats produced high levels of IL-1-like activity. In separate experiments IL-1 In contrast, con A-or PHA-stimulated spleen cells of arthritic rats produced significantly lower levels of IL-2 compared with their normal counterparts (Fig. 4) . The addition of exogenous IL-2 to 'arthritic' spleen cells did not restore to normal their ability to proliferate; indeed spleen cells of arthritic animals responded poorly or not at all to exogenous IL-2 (Table 3) . Furthermore, whereas con-Aactivated spleen cells from normal animals efficiently absorbed IL-2, con-A-activated spleen cells from arthritic animals did not (Fig. 5) .
Role of prostaglandins in hyporesponsiveness of spleen cells from arthritic rats. Prostaglandins are established mediators of inflammatory responses and have been long suspected to play an important role in articular destruction.1 2 In addition they suppress certain in-vitro immune functions, including mitogen proliferative responses and IL-2 synthesis. 819 Therefore we examined the role of prostaglandins in the reduced proliferative responses of spleen cells from arthritic rats. Table 4 shows that treatment of 'arthritic' spleen cells in vitro with 1075 M indomethacin, an inhibitor of prostaglandin synthesis,20 improved to some degree the ability of these cells to produce IL-2. However, indomethacin treatment did not restore this defect in 'arthritic' cells to normal levels, and IL-2 synthesis by normal cells was also increased by indomethacin treatment (Table 4 ).
The effects of exogenous PGE2 on the proliferative responses of normal and 'arthritic' 'arthritic' cells to con A (Fig. 6) . However, 10-5 M PGE2 significantly reduced proliferation of both normal and 'arthritic' cells to the same degree (50(70% inhibition of 3H-TdR uptake).
Discussion
The present study has shown that (1) spleen and peripheral blood lymphocytes from rats with arthritis due to M. butyricum injection proliferate poorly in vitro in response to con A, PHA, or PWM; (2) this state of hyporesponsiveness occurs with similar kinetics to and is correlated with the development of an articular arthritis; (3) splenic and peritoneal macrophages from arthritic rats produce normal or augmented levels of IL-1 in response to LPS; (4) con A-or PHA-stimulated cells from arthritic rats produce significantly lower amounts of IL-2 and, moreover, fail to bind and respond to this lymphokine; (5) indomethacin treatment of arthritic spleen cells does not restore to normal their deficient IL-2 synthesis; and (6) spleen cells from normal or arthritic rats are equally sensitive to the inhibitory effects of PGE2 on lymphocyte proliferation. We conclude that during the course of a M. butyricuminduced arthritic response a state of refractoriness of spleen and peripheral blood cells to in-vitro mitogen stimulation develops and this hyporesponsiveness is mediated, at least in part, by the reduced ability of 'arthritic' cells to produce and respond to IL-2. We suggest that lymphokine abnormalities play a role in the immunological imbalance observed in this experimental model of arthritic disease.
Our results confirm the findings of others that spleen cells from arthritic rats respond poorly in vitro to PHA and con A.2' 23 In addition we have examined these observations by documenting that a similar phenomenon occurs with a T-dependent B cell mitogen (PWM) and by dissecting the role of prostaglandin and lymphokine synthesis/responsiveness in mediating this splenic hyporesponsiveness.
Despite the generally observed immunepotentiating or adjuvant effect of Mycobacteria Sp24 spp.2 some investigators have reported decreased spleen cell proliferative responses in mice injected with large doses (33 mg) of BCG.25 26 Our data, however, indicate that the decreased spleen cell responsiveness in arthritic rats is not simply a consequence of exposure of the animals to M. butyricum but is in fact related to the development of an arthritic response. Thus spleen cell reactivity is normal in M. butyricum-injected animals which fail to develop arthritis, and both splenic hyporesponsiveness and arthritogenesis share a close temporal relationship. Moreover, our rats received 30-40-fold less mycobacterium (on a body weight basis) than is required to reduce splenic hyporeactivity in mice. 26 Because T cell proliferation in vitro is dependent on the synthesis and utilisation of IL-I and IL-2, 16 17 we examined the possibility that a dysregulation of this lymphokine cascade system could contribute to the reduced immune function in arthritic rats. In response to LPS the synthesis of IL-1 by splenic or peritoneal macrophage from arthritic rats equalled or exceeded that of macrophages obtained from normal animals. 
